An increase in the concentration of AChE in the brain results in the degradation of Ach, eventually reducing the ACh receptors and then inducing undesirable effect on cholinergic neurotransmission, and also results in impairment of cognitive function as well as other neurological disorders [40]. This evidence concerns the gene FGFR3 and nervous system disorder.